Table 4.
Comparison of various parameters between subjects with eVFA <100 cm2 and eVFA ≥100 cm2
| eVFA <100 cm2 group | eVFA ≥100 cm2 group | p value | |
|---|---|---|---|
| n (Male) |
31 |
103 |
|
| Age, years |
62±16 (25–86) |
65±11 (27–85) |
0.239 |
| BMI, kg/m2 |
21.7±1.9 (18.1-25.8) |
26.7±3.6 (20.6-38.5) |
<0.001 |
| WC, cm |
78.0±4.6 (68–90) |
94.4±9.0 (78–130) |
<0.001 |
| History of smoking (%) |
67.7 |
86.4 |
0.045 |
| Brinkman index |
591±699 (0–3000) |
795±652 (0–3520) |
0.136 |
| Hypertension (%) |
41.9 |
73.8 |
0.001 |
| SBP, mmHg |
127±17 (94–168) |
133±15 (98–180) |
0.048 |
| DBP, mmHg |
71±9 (52–91) |
78±11 (57–111) |
0.005 |
| Diabetes (%) |
71.0 |
80.6 |
0.254 |
| FBG, mg/dL |
119±35 (80–216) |
130±35 (56–261) |
0.123 |
| HbA1c, (NGSP),% |
6.8±1.1 (4.9-8.9) |
7.0±1.1 (5.4-10.7) |
0.292 |
| HOMA-IR, units |
2.0±1.9 (0.47-8.0) |
3.3±2.4 (0.63-14.1) |
0.038 |
| eGFR, mL/min |
72.3±16.8 (43.0-103.4) |
68.7±18.0 (24.4-110.6) |
0.346 |
| UACR, mg/g creatinine |
244.6±869.9 (0.5-3958) |
156.5±435.4 (1.0-2880) |
0.519 |
| Dyslipidemia (%) |
54.8 |
71.8 |
0.075 |
| T-cho, mg/dL |
198±38 (137.8-271) |
191±36 (112–335) |
0.349 |
| LDL-C, mg/dL |
117±35 (68–182) |
111±33 (55–259) |
0.337 |
| TG, mg/dL |
87±35 (32–182) |
159±97 (51–681) |
<0.001 |
| HDL-C, mg/dL | 63±24 (31–157) | 50±12 (56–261) | <0.001 |
Data are mean ± SEM (range), or number of subjects. Abbreviations as in Table 1. P values <0.05 were considered statistically significant.